Reasons why Karyopharm Therapeutics Inc.’s (NASDAQ:KPTI) fundamentals are futile
In yesterday’s Wall Street session, Karyopharm Therapeutics Inc. (NASDAQ:KPTI) shares traded at $1.60, up 7.38% from the previous session. 10 analysts cover Karyopharm Therapeutics Inc. (NASDAQ:KPTI), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $10.00 and a […]
Karyopharm Therapeutics Inc. [KPTI] attracts people because of its fundamentals
The stock of Karyopharm Therapeutics Inc. (NASDAQ:KPTI) last traded at $1.77, down -1.12% from the previous session. Data from the available sources indicates that Karyopharm Therapeutics Inc. (NASDAQ:KPTI) is covered by 10 analysts. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of […]
